Published in J Comput Aided Mol Des on March 01, 2005
Crystal structure of a type II dihydrofolate reductase catalytic ternary complex. Biochemistry (2007) 0.98
A fast flexible docking method using an incremental construction algorithm. J Mol Biol (1996) 7.33
Loop and subdomain movements in the mechanism of Escherichia coli dihydrofolate reductase: crystallographic evidence. Biochemistry (1997) 5.46
Construction and evaluation of the kinetic scheme associated with dihydrofolate reductase from Escherichia coli. Biochemistry (1987) 4.29
Comparative study of several algorithms for flexible ligand docking. J Comput Aided Mol Des (2003) 3.29
A review of protein-small molecule docking methods. J Comput Aided Mol Des (2002) 3.25
The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure. J Comput Aided Mol Des (1994) 3.12
The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin. J Am Chem Soc (1988) 3.07
Transposon Tn5090 of plasmid R751, which carries an integron, is related to Tn7, Mu, and the retroelements. J Bacteriol (1994) 2.97
Comparative evaluation of 11 scoring functions for molecular docking. J Med Chem (2003) 2.87
Knowledge-based scoring function to predict protein-ligand interactions. J Mol Biol (2000) 2.86
Assessing scoring functions for protein-ligand interactions. J Med Chem (2004) 2.41
Evaluation of the FLEXX incremental construction algorithm for protein-ligand docking. Proteins (1999) 2.30
Two distinct types of trimethoprim-resistant dihydrofolate reductase specified by R-plasmids of different compatibility groups. J Biol Chem (1977) 2.13
Comparative evaluation of eight docking tools for docking and virtual screening accuracy. Proteins (2004) 2.12
Consensus scoring: A method for obtaining improved hit rates from docking databases of three-dimensional structures into proteins. J Med Chem (1999) 2.11
Coupling interactions of distal residues enhance dihydrofolate reductase catalysis: mutational effects on hydride transfer rates. Biochemistry (2002) 2.09
Efficient docking of peptides to proteins without prior knowledge of the binding site. Protein Sci (2002) 1.97
Evaluation of docking performance: comparative data on docking algorithms. J Med Chem (2004) 1.79
Crystal structures of Escherichia coli dihydrofolate reductase: the NADP+ holoenzyme and the folate.NADP+ ternary complex. Substrate binding and a model for the transition state. Biochemistry (1990) 1.71
Consensus scoring for ligand/protein interactions. J Mol Graph Model (2002) 1.67
Characterization of a R plasmid-associated, trimethoprim-resistant dihydrofolate reductase and determination of the nucleotide sequence of the reductase gene. Nucleic Acids Res (1981) 1.63
Automated docking of ligands to an artificial active site: augmenting crystallographic analysis with computer modeling. J Comput Aided Mol Des (2003) 1.55
Screening a peptidyl database for potential ligands to proteins with side-chain flexibility. Proteins (1998) 1.25
Class 1 integrons mediate antibiotic resistance in the fish pathogen Aeromonas salmonicida worldwide. Microb Drug Resist (2001) 1.23
Binding site characteristics in structure-based virtual screening: evaluation of current docking tools. J Mol Model (2003) 1.20
A plasmid-encoded dihydrofolate reductase from trimethoprim-resistant bacteria has a novel D2-symmetric active site. Nat Struct Biol (1995) 1.12
The particle concept: placing discrete water molecules during protein-ligand docking predictions. Proteins (1999) 1.11
The COOH terminus of aminoglycoside phosphotransferase (3')-IIIa is critical for antibiotic recognition and resistance. J Biol Chem (1999) 1.06
[Trimethoprim resistance plasmids: transferability and incompatibility groups (author's transl)]. Ann Microbiol (Paris) (1977) 1.05
Unusual binding stoichiometries and cooperativity are observed during binary and ternary complex formation in the single active pore of R67 dihydrofolate reductase, a D2 symmetric protein. Biochemistry (1996) 0.94
On the detection of multiple-binding modes of ligands to proteins, from biological, structural, and modeling data. J Comput Aided Mol Des (2003) 0.94
Role of ionic interactions in ligand binding and catalysis of R67 dihydrofolate reductase. Biochemistry (2003) 0.92
Inhibition of isoprene biosynthesis pathway enzymes by phosphonates, bisphosphonates, and diphosphates. J Med Chem (2004) 0.87
A glutamine 67--> histidine mutation in homotetrameric R67 dihydrofolate reductase results in four mutations per single active site pore and causes substantial substrate and cofactor inhibition. Protein Eng (1997) 0.86
Interligand Overhauser effects in type II dihydrofolate reductase. Biochemistry (2001) 0.86
In search of dihydrofolate reductase. Protein Sci (1996) 0.85
Tyrosine 105 and threonine 212 at outermost substrate binding subsites -6 and +4 control substrate specificity, oligosaccharide cleavage patterns, and multiple binding modes of barley alpha-amylase 1. J Biol Chem (2003) 0.85
Vibrational structure of dihydrofolate bound to R67 dihydrofolate reductase. J Biol Chem (2001) 0.85
Role of S65, Q67, I68, and Y69 residues in homotetrameric R67 dihydrofolate reductase. Biochemistry (2001) 0.84
Progress toward virtual screening for drug side effects. Proteins (2002) 0.82
New dfr2 gene as a single-gene cassette in a class 1 integron from a trimethoprim-resistant Escherichia coli isolate. Microb Drug Resist (2003) 0.81
NMR studies of the interaction of a type II dihydrofolate reductase with pyridine nucleotides reveal unexpected phosphatase and reductase activity. Biochemistry (2003) 0.81
Creating artificial binding pocket boundaries to improve the efficiency of flexible ligand docking. J Chem Inf Comput Sci (2004) 0.81
Conformation of NADP+ bound to a type II dihydrofolate reductase. Biochemistry (1991) 0.80
Defining the binding site of homotetrameric R67 dihydrofolate reductase and correlating binding enthalpy with catalysis. Biochemistry (2004) 0.79
Breaking symmetry: mutations engineered into R67 dihydrofolate reductase, a D2 symmetric homotetramer possessing a single active site pore. Biochemistry (2002) 0.79
"Catch 222," the effects of symmetry on ligand binding and catalysis in R67 dihydrofolate reductase as determined by mutations at Tyr-69. J Biol Chem (2004) 0.79
A computational study of the binding of propidium to the peripheral anionic site of human acetylcholinesterase. J Med Chem (2004) 0.79
Structure of a ribonuclease B+d(pA)4 complex. Acta Crystallogr D Biol Crystallogr (1996) 0.78
Docking and molecular dynamics studies at trypanothione reductase and glutathione reductase active sites. J Mol Model (2002) 0.78
Mechanistic studies of R67 dihydrofolate reductase. Effects of pH and an H62C mutation. J Biol Chem (1997) 0.78
Role of Lys-32 residues in R67 dihydrofolate reductase probed by asymmetric mutations. J Biol Chem (2004) 0.78
Anomalous differences of light elements in determining precise binding modes of ligands to glycerol-3-phosphate dehydrogenase. Chem Biol (2002) 0.77
Investigation of glucose binding sites on insulin. Proteins (2004) 0.77
Structure of m-carboxyphenyl-alpha-D-galactopyranoside complexed to heat-labile enterotoxin at 1.3 A resolution: surprising variations in ligand-binding modes. Acta Crystallogr D Biol Crystallogr (2000) 0.77
One site fits both: a model for the ternary complex of folate + NADPH in R67 dihydrofolate reductase, a D2 symmetric enzyme. J Comput Aided Mol Des (2001) 0.76
Characterization and stereochemistry of cofactor oxidation by a type II dihydrofolate reductase. Biochemistry (1990) 0.76
Understanding protein structure-function relationships in Family 47 alpha-1,2-mannosidases through computational docking of ligands. Proteins (2002) 0.76
The C-type lectin-like domain superfamily. FEBS J (2005) 4.22
Green evolution and dynamic adaptations revealed by genomes of the marine picoeukaryotes Micromonas. Science (2009) 4.05
Combining docking and molecular dynamic simulations in drug design. Med Res Rev (2006) 1.70
Shadoo, a new protein highly conserved from fish to mammals and with similarity to prion protein. Gene (2003) 1.30
Comparative analysis of structural properties of the C-type-lectin-like domain (CTLD). Proteins (2003) 1.17
The prion protein gene: identifying regulatory signals using marsupial sequence. Gene (2005) 1.03
Conformation of prion protein repeat peptides probed by FRET measurements and molecular dynamics simulations. Biophys J (2004) 0.99
Evolution of vertebrate genes related to prion and Shadoo proteins--clues from comparative genomic analysis. Mol Biol Evol (2004) 0.98
Synthesis of quaternised 2-aminopyrimido[4,5-d]pyrimidin-4(3H)-ones and their biological activity with dihydrofolate reductase. Eur J Med Chem (2003) 0.97
Optimization of parameters for molecular dynamics simulation using smooth particle-mesh Ewald in GROMACS 4.5. J Comput Chem (2011) 0.96
Integron-sequestered dihydrofolate reductase: a recently redeployed enzyme. Trends Microbiol (2006) 0.90
Redefinition of rubisco carboxylase reaction reveals origin of water for hydration and new roles for active-site residues. J Am Chem Soc (2008) 0.89
Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children. Cochrane Database Syst Rev (2012) 0.88
C-type lectin-like domains in Fugu rubripes. BMC Genomics (2004) 0.87
Copper-induced conformational change in a marsupial prion protein repeat peptide probed using FTIR spectroscopy. FEBS Lett (2002) 0.84
An efficient Z-score algorithm for assessing sequence alignments. J Comput Biol (2004) 0.82
Identification of the RGG box motif in Shadoo: RNA-binding and signaling roles? Bioinform Biol Insights (2008) 0.81
Electronic information and clinical decision support for prescribing: state of play in Australian general practice. Fam Pract (2010) 0.80
Methyltetrahydrofolate:corrinoid/iron-sulfur protein methyltransferase (MeTr): protonation state of the ligand and active-site residues. J Phys Chem B (2009) 0.78
Experimental and calculated shift in pK(a) upon binding of phosphotyrosine peptide to the SH2 domain of p56(lck). Bioorg Med Chem (2002) 0.78
Computational methods for the study of enzymic reaction mechanisms III: a perturbation plus QM/MM approach for calculating relative free energies of protonation. J Comput Chem (2005) 0.77
Putative functional role for the invariant aspartate 263 residue of Rhodospirillum rubrum Rubisco. Biochemistry (2009) 0.76
Comparison of linear-scaling semiempirical methods and combined quantum mechanical/molecular mechanical methods for enzymic reactions. II. An energy decomposition analysis. J Comput Chem (2002) 0.76
Charge transfer effects in the GroEL-GroES chaperonin tetramer in solution. J Phys Chem B (2012) 0.75
NICE: alone in Europe but not the world. BMJ (2009) 0.75
Hepatic phospholipid changes induced by sustained oxygen supplementation. Pharmacol Toxicol (2002) 0.75